+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Manufacturing Market Research Report by Drug Development Type, Formulation, Therapy Area, Route of Administration Outlook, Prescription, Age Group, Distribution Channels, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 224 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 5454991
UP TO OFF until Dec 31st 2022
The Global Pharmaceutical Manufacturing Market size was estimated at USD 454.02 billion in 2021, USD 509.45 billion in 2022, and is projected to grow at a CAGR 12.38% to reach USD 914.90 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmaceutical Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Drug Development Type, the market was studied across In-house and Outsource.
  • Based on Formulation, the market was studied across Capsules, Injectable, Powders, Sprays, Suspensions, and Tablets.
  • Based on Therapy Area, the market was studied across Cancer, Cardiovascular Diseases, Diabetes, Pain, and Respiratory Diseases.
  • Based on Route of Administration Outlook, the market was studied across Inhalations, Oral, Parenteral, and Topical.
  • Based on Prescription, the market was studied across Over-the-counter (OTC) Medicines and Prescription Medicines.
  • Based on Age Group, the market was studied across Adults, Children & Adolescents, and Geriatric.
  • Based on Distribution Channels, the market was studied across Non-retail and Retail.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Manufacturing Market, including Actiza Pharmaceutical Pvt. Ltd., Aenova Group GmbH, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim Group, Bristol-Myers Squibb, Catalent Inc., Eli Lilly And Company, F. Hoffmann-La Roche Ltd., Famar SA, GlaxoSmithKline PLC, Johnson & Johnson Private Limited, Lonza Group AG, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Piramal Pharma Solutions, Recipharm AB, Sanofi S.A., and Sun Pharmaceutical Industries Limited.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pharmaceutical Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Manufacturing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Manufacturing Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in global demand for vaccines and drugs
5.1.1.2. Growing pharmaceutical R&D spending
5.1.1.3. Growth in geriatric population and incidence rate of chronic disorders
5.1.2. Restraints
5.1.2.1. Patent expiration of profitable drugs
5.1.3. Opportunities
5.1.3.1. Rise in focus towards healthcare needs of emerging nations
5.1.3.2. Rise in the investment and funding programs in pharmaceutical manufacturing sector
5.1.3.3. Emergence in the advancements of pharmaceutical manufacturing technologies
5.1.4. Challenges
5.1.4.1. Logistics complexities and limited skilled professionals
5.2. Cumulative Impact of COVID-19
6. Pharmaceutical Manufacturing Market, by Drug Development Type
6.1. Introduction
6.2. In-house
6.3. Outsource
7. Pharmaceutical Manufacturing Market, by Formulation
7.1. Introduction
7.2. Capsules
7.3. Injectable
7.4. Powders
7.5. Sprays
7.6. Suspensions
7.7. Tablets
8. Pharmaceutical Manufacturing Market, by Therapy Area
8.1. Introduction
8.2. Cancer
8.3. Cardiovascular Diseases
8.4. Diabetes
8.5. Pain
8.6. Respiratory Diseases
9. Pharmaceutical Manufacturing Market, by Route of Administration Outlook
9.1. Introduction
9.2. Inhalations
9.3. Oral
9.4. Parenteral
9.5. Topical
10. Pharmaceutical Manufacturing Market, by Prescription
10.1. Introduction
10.2. Over-the-counter (OTC) Medicines
10.3. Prescription Medicines
11. Pharmaceutical Manufacturing Market, by Age Group
11.1. Introduction
11.2. Adults
11.3. Children & Adolescents
11.4. Geriatric
12. Pharmaceutical Manufacturing Market, by Distribution Channels
12.1. Introduction
12.2. Non-retail
12.3. Retail
13. Americas Pharmaceutical Manufacturing Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Pharmaceutical Manufacturing Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
15. Europe, Middle East & Africa Pharmaceutical Manufacturing Market
15.1. Introduction
15.2. France
15.3. Germany
15.4. Italy
15.5. Netherlands
15.6. Qatar
15.7. Russia
15.8. Saudi Arabia
15.9. South Africa
15.10. Spain
15.11. United Arab Emirates
15.12. United Kingdom
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Actiza Pharmaceutical Pvt. Ltd.
17.2. Aenova Group GmbH
17.3. AstraZeneca PLC
17.4. Bayer AG
17.5. Boehringer Ingelheim Group
17.6. Bristol-Myers Squibb
17.7. Catalent Inc.
17.8. Eli Lilly And Company
17.9. F. Hoffmann-La Roche Ltd.
17.10. Famar SA
17.11. GlaxoSmithKline PLC
17.12. Johnson & Johnson Private Limited
17.13. Lonza Group AG
17.14. Merck & Co., Inc.
17.15. Novartis AG
17.16. Pfizer, Inc.
17.17. Piramal Pharma Solutions
17.18. Recipharm AB
17.19. Sanofi S.A.
17.20. Sun Pharmaceutical Industries Limited
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET DYNAMICS
FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2021 VS 2027 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2027
FIGURE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2021 VS 2027 (%)
FIGURE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2021 VS 2027 (USD BILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2027
FIGURE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, 2019-2027 (USD BILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, 2019-2027 (USD BILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, 2019-2027 (USD BILLION)
FIGURE 27. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 28. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, 2019-2027 (USD BILLION)
FIGURE 29. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 30. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2021 VS 2027 (%)
FIGURE 31. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2021 VS 2027 (USD BILLION)
FIGURE 32. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2027
FIGURE 33. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, 2019-2027 (USD BILLION)
FIGURE 34. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 35. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, 2019-2027 (USD BILLION)
FIGURE 36. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 37. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, 2019-2027 (USD BILLION)
FIGURE 38. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 39. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, 2019-2027 (USD BILLION)
FIGURE 40. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 41. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, 2019-2027 (USD BILLION)
FIGURE 42. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 43. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2021 VS 2027 (%)
FIGURE 44. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2021 VS 2027 (USD BILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2027
FIGURE 46. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, 2019-2027 (USD BILLION)
FIGURE 47. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 48. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, 2019-2027 (USD BILLION)
FIGURE 49. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 50. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, 2019-2027 (USD BILLION)
FIGURE 51. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 52. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2019-2027 (USD BILLION)
FIGURE 53. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 54. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2021 VS 2027 (%)
FIGURE 55. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2021 VS 2027 (USD BILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2027
FIGURE 57. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, 2019-2027 (USD BILLION)
FIGURE 58. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 59. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, 2019-2027 (USD BILLION)
FIGURE 60. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 61. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (%)
FIGURE 62. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2021 VS 2027 (USD BILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2027
FIGURE 64. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, 2019-2027 (USD BILLION)
FIGURE 65. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 66. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, 2019-2027 (USD BILLION)
FIGURE 67. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 68. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, 2019-2027 (USD BILLION)
FIGURE 69. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 70. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2021 VS 2027 (%)
FIGURE 71. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2021 VS 2027 (USD BILLION)
FIGURE 72. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2027
FIGURE 73. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, 2019-2027 (USD BILLION)
FIGURE 74. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 75. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, 2019-2027 (USD BILLION)
FIGURE 76. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 77. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 78. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 79. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 80. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2027
FIGURE 81. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 82. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 83. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 84. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 85. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 86. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 87. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 88. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2027
FIGURE 89. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 90. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 91. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 92. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2027
FIGURE 93. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 94. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 95. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 96. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 97. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 98. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 99. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 100. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 101. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 102. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 103. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 105. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 106. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 107. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2027
FIGURE 108. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 109. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 110. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 111. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 112. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 113. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 114. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 115. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 116. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 117. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 118. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 119. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 120. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 121. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL MANUFACTURING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OUTSOURCE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2019-2027 (USD BILLION)
TABLE 18. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY STATE, 2019-2027 (USD BILLION)
TABLE 20. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY REGION, 2019-2027 (USD BILLION)
TABLE 23. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY STATE, 2019-2027 (USD BILLION)
TABLE 25. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY REGION, 2019-2027 (USD BILLION)
TABLE 28. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY STATE, 2019-2027 (USD BILLION)
TABLE 30. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDERS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY REGION, 2019-2027 (USD BILLION)
TABLE 33. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY STATE, 2019-2027 (USD BILLION)
TABLE 35. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SPRAYS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2019-2027 (USD BILLION)
TABLE 38. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY STATE, 2019-2027 (USD BILLION)
TABLE 40. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2019-2027 (USD BILLION)
TABLE 43. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 44. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY STATE, 2019-2027 (USD BILLION)
TABLE 45. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLETS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 48. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, BY REGION, 2019-2027 (USD BILLION)
TABLE 49. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, BY STATE, 2019-2027 (USD BILLION)
TABLE 51. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 52. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 53. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 54. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 55. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 56. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 58. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY REGION, 2019-2027 (USD BILLION)
TABLE 59. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 60. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD BILLION)
TABLE 61. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 63. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, BY REGION, 2019-2027 (USD BILLION)
TABLE 64. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 65. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, BY STATE, 2019-2027 (USD BILLION)
TABLE 66. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PAIN, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 68. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2019-2027 (USD BILLION)
TABLE 69. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 70. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY STATE, 2019-2027 (USD BILLION)
TABLE 71. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY DISEASES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 73. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 74. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY REGION, 2019-2027 (USD BILLION)
TABLE 75. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 76. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY STATE, 2019-2027 (USD BILLION)
TABLE 77. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INHALATIONS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 79. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY REGION, 2019-2027 (USD BILLION)
TABLE 80. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 81. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY STATE, 2019-2027 (USD BILLION)
TABLE 82. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ORAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 84. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY REGION, 2019-2027 (USD BILLION)
TABLE 85. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 86. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY STATE, 2019-2027 (USD BILLION)
TABLE 87. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 89. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY REGION, 2019-2027 (USD BILLION)
TABLE 90. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 91. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY STATE, 2019-2027 (USD BILLION)
TABLE 92. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 94. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 95. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY REGION, 2019-2027 (USD BILLION)
TABLE 96. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 97. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY STATE, 2019-2027 (USD BILLION)
TABLE 98. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY OVER-THE-COUNTER (OTC) MEDICINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 100. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY REGION, 2019-2027 (USD BILLION)
TABLE 101. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 102. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY STATE, 2019-2027 (USD BILLION)
TABLE 103. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION MEDICINES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 105. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 106. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 107. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 108. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 109. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ADULTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 111. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY REGION, 2019-2027 (USD BILLION)
TABLE 112. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 113. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY STATE, 2019-2027 (USD BILLION)
TABLE 114. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CHILDREN & ADOLESCENTS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 116. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY REGION, 2019-2027 (USD BILLION)
TABLE 117. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 118. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY STATE, 2019-2027 (USD BILLION)
TABLE 119. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 121. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 122. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY REGION, 2019-2027 (USD BILLION)
TABLE 123. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 124. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY STATE, 2019-2027 (USD BILLION)
TABLE 125. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NON-RETAIL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 127. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY REGION, 2019-2027 (USD BILLION)
TABLE 128. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 129. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY STATE, 2019-2027 (USD BILLION)
TABLE 130. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RETAIL, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 132. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 133. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 134. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 135. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 136. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 137. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 138. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 139. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 140. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 141. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 142. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 143. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 144. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 145. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 146. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 147. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 148. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 149. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 150. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 151. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 152. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 153. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 154. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 155. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 156. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 157. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 158. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 159. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 160. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 161. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 162. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 163. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 164. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 165. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 166. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 167. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 168. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 169. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 170. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 171. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 172. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 173. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 174. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 175. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 176. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 177. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 178. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 179. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 180. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 181. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 182. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 183. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 184. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 185. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 186. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 187. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 188. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 189. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 190. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 191. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 192. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 193. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 194. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 195. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 196. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 197. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 198. AUSTRALIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 199. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 200. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 201. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 202. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 203. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 204. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 205. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 206. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 207. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 208. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 209. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 210. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 211. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 212. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 213. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 214. INDIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 215. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 216. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 217. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 218. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 219. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 220. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 221. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 222. INDONESIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 223. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 224. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 225. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 226. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 227. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 228. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 229. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 230. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 231. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 232. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 233. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 234. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 235. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 236. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 237. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 238. MALAYSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 239. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 240. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 241. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 242. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 243. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 244. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 245. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 246. PHILIPPINES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 247. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 248. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 249. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 250. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 251. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 252. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 253. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 254. SINGAPORE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 255. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 256. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 257. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 258. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 259. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 260. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 261. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 262. SOUTH KOREA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 263. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 264. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 265. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 266. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 267. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 268. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 269. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 270. TAIWAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 271. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 272. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 273. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 274. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 275. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 276. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 277. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 278. THAILAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 288. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 289. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 2019-2027 (USD BILLION)
TABLE 290. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION, 2019-2027 (USD BILLION)
TABLE 291. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPY AREA, 2019-2027 (USD BILLION)
TABLE 292. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ROUTE OF ADMINISTRATION OUTLOOK, 2019-2027 (USD BILLION)
TABLE 293. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PRESCRIPTION, 2019-2027 (USD BILLION)
TABLE 294. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2019-2027 (USD BILLION)
TABLE 295. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNELS, 2019-2027 (USD BILLION)
TABLE 296. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 297. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT TYPE, 20

Companies Mentioned

  • Actiza Pharmaceutical Pvt. Ltd.
  • Aenova Group GmbH
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim Group
  • Bristol-Myers Squibb
  • Catalent Inc.
  • Eli Lilly And Company
  • F. Hoffmann-La Roche Ltd.
  • Famar SA
  • GlaxoSmithKline PLC
  • Johnson & Johnson Private Limited
  • Lonza Group AG
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Piramal Pharma Solutions
  • Recipharm AB
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited

Methodology

Loading
LOADING...